OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

SMC CORP./  JP3162600005  /

Frankfurt
2024-04-23  8:01:56 AM Chg. +4.0000 Volume Bid10:06:38 AM Ask10:06:38 AM Market Capitalization Dividend Y. P/E Ratio
470.0000EUR +0.86% 0
Turnover: 0.0000		 464.0000Bid Size: 12 474.0000Ask Size: 12 30.57 bill.EUR - -
GlobeNewswire 04-18 Core Molding Technologies Announces Timing of First Quarter Fiscal Year 2024 Results
GlobeNewswire 04-16 Core Molding Technologies Presented with a 2024 BRP Gold Supplier Award
GlobeNewswire 04-10 Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire 04-08 GLP Works with Foundry for AI by Rackspace (FAIR) Experts to Integrate Microsoft Azure OpenAI Servic...
GlobeNewswire 03-25 Core Molding Technologies Promotes Eric L. Palomaki to Chief Operating Officer
GlobeNewswire 03-13 Core Molding Technologies to Participate in the 36th Annual Roth Conference
GlobeNewswire 03-12 Core Molding Technologies Reports Full Year and Fourth Quarter 2023 Results
GlobeNewswire 03-11 Core Molding Technologies Announces $7,500,000 Stock Repurchase Program
GlobeNewswire 02-22 Bitech Technologies Appoints Sid Sung as Its New Chief Innovation Officer to Lead the Digital Revolu...
GlobeNewswire 02-15 Core Molding Technologies Announces Timing of Fourth Quarter and Fiscal Year 2023 Results
GlobeNewswire 02-07 Liferay Announces Partner of the Year Award Winners
GlobeNewswire 02-06 Applied Materials Announces Supplier Excellence Awards
GlobeNewswire 01-23 Rezolute Receives Innovation Passport Designation from the U.K. Innovative Licensing and Access Path...
GlobeNewswire 01-05 PSYC’s CEO Provides Detailed Update on the State of the Company in Newly Released Podcast Recording
GlobeNewswire 2023-12-29 Visionary Leadership: HMG Strategy, the World’s #1 Executive Leadership Network, Looks Ahead to its ...
GlobeNewswire 2023-11-30 Object Management Group Announces Managed Communities Program
GlobeNewswire 2023-11-30 Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repiri...
GlobeNewswire 2023-11-28 Ambrx Provides Update On APEX-01, an On-Going Phase 1 / 2 Dose Escalation Study Evaluating ARX517, a...
GlobeNewswire 2023-11-27 ADvantage Therapeutics Has Commenced Enrollment for Its Phase 2b Clinical Trial of AD04™ for Treatme...
GlobeNewswire 2023-11-13 Core Molding Technologies Presenting at the 15th Annual Southwest IDEAS Investor Conference on Novem...
GlobeNewswire 2023-11-08 PSYC’s CEO to Moderate Panel at The Cannabis & Psychedelics Investment Summit Hosted by Kahner Globa...
GlobeNewswire 2023-11-08 Algernon Pharmaceuticals Receives Japanese Patent Notice of Allowance for Treatment of NASH with Rep...
GlobeNewswire 2023-11-07 Core Molding Technologies Reports Fiscal 2023 Third Quarter Results
GlobeNewswire 2023-11-02 Core Molding Technologies Appoints New Board Member
GlobeNewswire 2023-11-01 Amarin Reports Third Quarter 2023 Financial Results